BLCM Shares Outstanding History



Below is a table of the BLCM shares outstanding history going back to 12/18/2014:

Date BLCM Shares Outstanding
12/18/20142.48M
3/15/20152.64M
4/30/20152.64M
7/31/20152.65M
10/30/20152.65M
2/29/20162.70M
4/29/20162.70M
7/29/20162.70M
10/28/20162.71M
2/28/20172.72M
4/28/20173.31M
7/28/20173.32M
11/3/20173.33M
2/28/20183.36M
4/30/20184.29M
7/31/20184.33M
10/31/20184.34M
3/1/20194.43M
4/30/20194.60M
7/31/20194.63M
10/31/20194.96M
2/6/20204.96M
2/28/20205.05M
5/1/20205.05M
7/31/20205.06M
10/30/20205.06M
3/22/20218.32M
5/10/20218.40M
8/4/20218.40M
10/27/20218.40M
3/21/20228.55M
5/9/20228.61M
11/4/20228.61M
3/24/20239.05M
3/31/20239.05M
5/9/20239.50M

Also see: BLCM Market Cap History
BLCM YTD Return
BLCM Historical Shares Outstanding:
+17.36% CAGR
BLCM Historical Shares Outstanding: +17.36% CAGR

Mouse over chart for data details
12/18/2014 ...5/9/2023
Bellicum Pharmaceuticals is a biopharmaceutical company focused on discovering and developing controllable cellular immunotherapies for the treatment of various forms of cancer. Co. is developing chimeric antigen receptors (CAR)-T cell therapies, which are an approach in which a patient's or donor's T cells are genetically modified to carry CARs. By incorporating its switch technologies, Co. is developing product candidates in various areas of cellular immunotherapy including BPX-601, which is designed to treat solid tumors expressing prostate stem cell antigen; and BPX-603, which is designed to target solid tumors that express the human epidermal growth factor receptor 2 antigen. We show 36 historical shares outstanding datapoints in our coverage of BLCM's shares outstanding history.

Understanding the changing numbers of BLCM shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like BLCM versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching BLCM by allowing them to research BLCM shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree BLCM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Bellicum Pharmaceuticals (BLCM) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

BLFS Shares Outstanding History
BLI Shares Outstanding History
BLPH Shares Outstanding History
BLRX Shares Outstanding History
BLUE Shares Outstanding History
BMEA Shares Outstanding History
BMRA Shares Outstanding History
BMRN Shares Outstanding History
BMY Shares Outstanding History
BNGO Shares Outstanding History
More Healthcare companies »

 

BLCM Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.